Fulltext

Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate

Meyer JP 1 , Cepeda J 2 , Wu J 3 , Trestman RL 3 , Altice FL 4 , Springer SA 5

Affiliations 

  • 1 AIDS Program, Yale University School of Medicine, New Haven, Connecticut2Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut
  • 2 Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut
  • 3 Correctional Managed Healthcare, University of Connecticut, Farmington
  • 4 AIDS Program, Yale University School of Medicine, New Haven, Connecticut3Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut5Centre of Excellence on Research in AIDS, University of Malaya, Kuala Lumpur, Mala
  • 5 AIDS Program, Yale University School of Medicine, New Haven, Connecticut
JAMA Intern Med, 2014 May;174(5):721-9.
PMID: 24687044 DOI: 10.1001/jamainternmed.2014.601

Abstract

Human immunodeficiency virus (HIV) management in correctional settings is logistically feasible, but HIV-related outcomes before release have not been recently systematically examined.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications